Showing 1 - 15 results of 15 for search 'Richard E Kast', query time: 0.05s Refine Results
  1. 1
    The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive

    The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive by Richard E. Kast

    Published 2023-10-01
    Get full text
    Article
  2. 2
    Ribavirin in Cancer Immunotherapies: Controlling Nitric Oxide Augments Cytotoxic Lymphocyte Function

    Ribavirin in Cancer Immunotherapies: Controlling Nitric Oxide Augments Cytotoxic Lymphocyte Function by Richard E. Kast

    Published 2003-01-01
    Get full text
    Article
  3. 3
    Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma Chemoirradiation

    Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma Chemoirradiation by Richard E. Kast

    Published 2021-02-01
    Get full text
    Article
  4. 4
    High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth—Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen

    High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth—Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen by Richard E. Kast

    Published 2022-10-01
    Get full text
    Article
  5. 5
    Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia

    Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia by Richard E. Kast

    Published 2018-07-01
    Get full text
    Article
  6. 6
    Glioblastoma: Looking at the Currently Marketed Sigma-1 Agonists, Antagonists

    Glioblastoma: Looking at the Currently Marketed Sigma-1 Agonists, Antagonists by Richard E Kast

    Published 2007-08-01
    Get full text
    Article
  7. 7
    Paths for Improving Bevacizumab Available in 2018: The ADZT Regimen for Better Glioblastoma Treatment

    Paths for Improving Bevacizumab Available in 2018: The ADZT Regimen for Better Glioblastoma Treatment by Richard E. Kast

    Published 2018-09-01
    Get full text
    Article
  8. 8
    Dapsone Lowers Neutrophil to Lymphocyte Ratio and Mortality in COVID-19 Patients Admitted to the ICU

    Dapsone Lowers Neutrophil to Lymphocyte Ratio and Mortality in COVID-19 Patients Admitted to the ICU by Badar Kanwar, Asif Khattak, Richard E. Kast

    Published 2022-12-01
    Get full text
    Article
  9. 9
    OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs

    OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs by Richard E. Kast, Marc-Eric Halatsch, Rafael Rosell

    Published 2021-05-01
    Get full text
    Article
  10. 10
    Benefits of Using Dapsone in Patients Hospitalized with COVID-19

    Benefits of Using Dapsone in Patients Hospitalized with COVID-19 by Badar A. Kanwar, Asif Khattak, Jenny Balentine, Jong Hoon Lee, Richard E. Kast

    Published 2022-01-01
    Get full text
    Article
  11. 11
    Involvement of MicroRNA in T-Cell Differentiation and Malignancy

    Involvement of MicroRNA in T-Cell Differentiation and Malignancy by Najmaldin Saki, Saeid Abroun, Masoud Soleimani, Saeideh Hajizamani, Mohammad Shahjahani, Richard E Kast, Yousef Mortazavi

    Published 2015-03-01
    Get full text
    Article
  12. 12
    A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen

    A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen by Richard E. Kast, Alex P. Michael, Iacopo Sardi, Terry C. Burns, Tim Heiland, Georg Karpel-Massler, Francois G. Kamar, Marc-Eric Halatsch

    Published 2020-01-01
    Get full text
    Article
  13. 13
    Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen

    Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen by Richard E. Kast, Nicolas Skuli, Iacopo Sardi, Felix Capanni, Martin Hessling, Guido Frosina, Anton P. Kast, Georg Karpel-Massler, Marc-Eric Halatsch

    Published 2018-11-01
    Get full text
    Article
  14. 14
    MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen

    MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen by Richard E. Kast, Alex Alfieri, Hazem I. Assi, Terry C. Burns, Ashraf M. Elyamany, Maria Gonzalez-Cao, Georg Karpel-Massler, Christine Marosi, Michael E. Salacz, Iacopo Sardi, Pieter Van Vlierberghe, Mohamed S. Zaghloul, Marc-Eric Halatsch

    Published 2022-05-01
    Get full text
    Article
  15. 15
    COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs

    COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs by Jong Hoon Lee, Badar Kanwar, Asif Khattak, Jenny Balentine, Ngoc Huy Nguyen, Richard E. Kast, Chul Joong Lee, Jean Bourbeau, Eric L. Altschuler, Consolato M. Sergi, Tuan Ngoc Minh Nguyen, Sangsuk Oh, Mun-Gi Sohn, Michael Coleman

    Published 2022-10-01
    Get full text
    Article

Search Tools: